Location: Home
  • search
  • go
  • Relate News
  • 1/16/2025Conjustar Biotech Completes CNY 100M Series Pre-A+ Financing
  • 1/16/2025Alphamab Advances Oncology Pipeline with Phase 2 Trial of TROP-2/HER3 ...
  • 1/16/2025Menarini and Insilico Forge Strategic Partnership to Address Unmet Nee...
  • 1/16/2025Hengrui Pharma Poised for Global Expansion, Eyes More Deals
  • 1/16/2025'The Bar Has Risen': China's Biotech Gains Push US Companies to Adapt ...
  • 1/16/2025The Rise of China Innovation in the Time of Trump (BioSpace)
  • 1/15/2025China Biopharma Tracker 2024 (PharmaDJ)
  • 1/15/2025China Announces Major Policy Incentives for Life Sciences Companies (R...
  • 1/15/2025Evolving innovation strategies in China for multinational companies (A...
  • 1/15/2025At JPM, Biotech Industry Expresses Excitement — and Some Anxiety — A...
  • 1/15/2025Chengdu MedGenCell Secures Strategic Investment for Cell Therapy Innov...
  • 1/15/2025Longen Therapeutics Secures Over CNY 100M in Pre-A Financing
  • 1/15/2025Ucello Wins FDA IND Approval for Pioneering Allogeneic CAR-T Therapy
  • 1/15/2025Luye Pharma Advances CNS Pipeline with Phase II Trial for LY03015 in C...
  • 1/15/2025U.S. Tightens Export Controls on Biotech Equipment Over AI and Securit...
  • 1/14/2025Ikena and Inmagene Biopharma Agree to Merger Deal
  • 1/14/2025CR Pharma Partners with NAMI to Explore Palbociclib for Alzheimer's Tr...
  • 1/14/2025Biophytis Enters Exclusive Negotiations with a Chinese Pharma Firm to ...
  • 1/14/2025ImmuneOnco Begins Trial of Instil's NSCLC Drug in China
  • 1/14/2025NHSA Hosts Roundtable on Supporting Innovative Drug Development
  • 1/13/2025Vertex, Zai Lab Enter Asian Licensing Pact for Povetacicept
  • 1/13/2025AbbVie and Simcere Zaiming Forge Partnership for a Novel Trispecific A...
  • 1/13/2025Hengruiand Kailera Report Positive Data from Phase 2 Obesity Trial of ...
  • 1/13/2025J&J's Balversa (Erdafitinib) Gains NMPA Approval for Advanced Urotheli...
  • 1/13/2025Livzon Group Discontinues LZM009 PD-1 Program Amid Strategic Rethink ...
  • 1/13/2025Regor Releases Phase 2a Topline Results for GLP-1 RGT-075
  • 1/13/2025Akeso Launches Phase 3 Trial for Ivonescimab (AK112)
  • 1/13/2025Okejian Bio Secures CNY 100M+ in Series A Financing to Advance Innova...
  • 1/13/2025CirCode Receives NMPA IND Approval for HM2002 Injection
  • 1/13/2025Gentize Biopharma Secures ~CNY 100M in Pre-A Financing to Advance Vacc...
  • Page:15/761 Total number of articles:22823: [First][<<] [13] [14] [15] [16] [17] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group